title: Managing vesicant extravasations.
abstract: Extravasation is an unusual but potentially severe complication of vesicant chemotherapy administration. Some extravasation injuries prompt litigation and the oncologist's actions, or lack of action, are scrutinized in the courtroom. This article presents advice and recommendations for treating patients who receive vesicants and includes a discussion of FDA-approved vesicant extravasation treatments and antidotes.
authors: LisaSchulmeister@hotmail.com
authors: Lisa
authors: L
authors: Schulmeister
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000628:therapy*; D006801:Humans; D007509:Irritants / Q000009:adverse effects*; D016365:Liability, Legal; D009336:Necrosis / Q000209:etiology / Q000517:prevention & control*; D009369:Neoplasms / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents; D007509:Irritants